middle.news
Cleo Diagnostics Unveils 2 Million-Strong U.S. Market for Ovarian Cancer Test
9:28am on Thursday 6th of November, 2025 AEDT
•
Healthcare
Read Story
Cleo Diagnostics Unveils 2 Million-Strong U.S. Market for Ovarian Cancer Test
9:28am on Thursday 6th of November, 2025 AEDT
Key Points
Updated U.S. insurance data reveals ~2 million women annually eligible for CLEO’s test
Total addressable market expanded from initial estimates based on comprehensive insurer claims
Health economic study underway to support reimbursement and market adoption
CLEO’s test offers superior diagnostic accuracy over existing methods like CA125
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE